← Open Payments lookup

PETER PANZARINO: Open Payments

NPI 1093798928 · MONTICELLO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,442 in 108 payments from 14 companies in 2025. Trend: 2023 $2,272 · 2024 $3,139 · 2025 $2,442

Food & beverage: $2,330Education: $111
CompanyPaymentsAmount
ABBVIE INC.34$819
Teva Pharmaceuticals USA, Inc.20$562
Otsuka America Pharmaceutical, Inc.12$195
Neurocrine BioSciences, Inc.6$163
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$110
Axsome Therapeutics, Inc.5$96
Janssen Pharmaceuticals, Inc5$94
E.R. Squibb & Sons, L.L.C.4$82
Vanda Pharmaceuticals Inc.3$82
Indivior Inc.4$75

Products named: VRAYLAR, AUSTEDO XR, INGREZZA, CAPLYTA, ABILIFY ASIMTUFII, Auvelity, INVEGA SUSTENNA, REXULTI.

Industry payments across NY — which companies pay providers there.